# US 2008/0306579 A1 · Drug Loaded Implantable Medical Device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306579 A1
- Document ID: US20080306579A1
- Status: Published application
- Kind: A1
- Application number: 11/760,499
- Filed: 2007-06-08
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: Medtronic Vascular, Inc.
- Inventors: Mark Dolan; Susan Rea; John Kantor
- Web page: https://patentgrep.com/patent/US20080306579A1

## CPC

- A61F 2/91: made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F 2230/0054: V-shaped
- A61F 2250/0068: the pharmaceutical product being in a reservoir
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A drug eluting implantable device includes an exterior surface on the device and at least one recess formed in the exterior surface. The device further include at least one sidewall protruding from the exterior surface adjacent the at least one recess defining a channel with the recess into which the drug may be loaded, the sidewall including a perpendicular portion substantially perpendicular to the exterior surface and the sidewall further including a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle greater than about 90 degrees as measured with reference to the exterior surface

## Claims

### Claim 1

A drug eluting implantable device comprising:
an exterior surface on the device;
at least one recess formed in the exterior surface; and
at least one sidewall protruding from the exterior surface adjacent the at least one recess defining a channel with the recess into which the drug may be loaded, the sidewall including a perpendicular portion substantially perpendicular to the exterior surface and the sidewall further including a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle greater than about 90 degrees as measured with reference to the exterior surface.

### Claim 2 (depends on 1)

The device of claim 1 wherein the parallel portion is substantially parallel to a lower surface of the recess.

### Claim 3 (depends on 1)

The device of claim 1 further comprising a therapeutic agent disposed within the recess.

### Claim 4 (depends on 1)

The device of claim 1 wherein the sidewall is formed of material skived from the surface to form the recess.

### Claim 5 (depends on 1)

The device of claim 1 wherein the device is a stent stamped from a flat sheet of material forming a plurality of struts defining the exterior surface of the stent, the flat sheet having two longitudinal edges and designed to be joined together to form a cylindrical stent.

### Claim 6 (depends on 1)

The device of claim 1 wherein the device is a stent consisting of a plurality of segments, each segment stamped from a flat sheet of material and bent into a sinusoidal ring to form struts of the stent, the sinusoidal ring having certain points defined as a peak deviation from a stent centerline and some of the points of one segment designed to be joined to some points of another segment to form the stent.

### Claim 7 (depends on 1)

The device of claim 1 wherein the device is a stent consisting of a plurality of wires formed into struts which define the exterior surface of the stent and the wires being joined to form the stent.

### Claim 8 (depends on 1)

The device of claim 1 further comprising:
at least one second sidewall on the exterior surface, the second sidewall separated from the first sidewall by the recess and connected to the first sidewall via a lower surface of the recess, each second sidewall protruding from the exterior surface substantially perpendicularly; and the second sidewall including a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle less than about 90 degrees as measured with reference to the exterior surface.

### Claim 9

A system for treating a vascular condition, the system comprising:
a catheter; and
a stent carried on the catheter, the stent including an exterior surface on the device, at least one recess formed in the exterior surface, and at least one sidewall protruding from the exterior surface adjacent the at least one recess defining a channel with the recess into which the drug may be loaded, the sidewall including a perpendicular portion substantially perpendicular to the exterior surface and the sidewall further including a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle greater than about 90 degrees as measured with reference to the exterior surface.

### Claim 10 (depends on 9)

The system of claim 9 wherein the parallel portion is substantially parallel to a lower surface of the recess.

### Claim 11 (depends on 9)

The system of claim 9 further comprising a therapeutic agent disposed within the recess.

### Claim 12 (depends on 9)

The system of claim 9 wherein the stent further comprises at least one second sidewall on the exterior surface, the second sidewall separated from the first sidewall by the recess and connected to the first sidewall via a lower surface of the recess, each second sidewall protruding from the exterior surface substantially perpendicularly; and the second sidewall including a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle less than about 90 degrees as measured with reference to the exterior surface.

### Claim 13

A method of forming a drug carrying device, the method comprising:
receiving a medical device for implantation within a body lumen;
skiving at least a first recess on an exterior surface of the medical device;
forming at least one first sidewall based on the skiving, each first sidewall protruding from the exterior surface substantially perpendicularly; and
swaging the at least one formed first sidewall to form a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle greater than about 90 degrees as measured with reference to the exterior surface.

### Claim 14 (depends on 13)

The method of claim 13 further comprising applying a therapeutic agent to the recess prior to swaging the formed sidewall.

### Claim 15 (depends on 13)

The method of claim 13 further comprising:
skiving at least one second sidewall on an exterior surface, the second sidewall separated from the first sidewall by the recess and connected to the first sidewall via a lower surface of the recess, each first sidewall protruding from the exterior surface substantially perpendicularly; and
swaging the second sidewall to form a parallel portion extending from the perpendicular portion, the parallel portion extending from the perpendicular portion at an angle less than about 90 degrees as measured with reference to the exterior surface.

### Claim 16

A drug eluting implantable device comprising:
a framework comprising at least one stent wire, the framework including at least one inner surface defining a lumen and at least one outer surface opposing the inner surface;
at least one depot disposed on at least a portion of the outer surface, the depot including at least one wall portion defining an axis offset from the outer surface.

### Claim 17 (depends on 16)

The device of claim 16 wherein the at least one depot further comprises a base surface substantially parallel with the outer surface.

### Claim 18 (depends on 16)

The device of claim 16 wherein the at least one depot further comprises a base surface offset from the outer surface.

### Claim 19 (depends on 16)

The device of claim 16 wherein the depot is formed as an integral portion of the framework.

### Claim 20 (depends on 16)

The device of claim 16 wherein the depot is affixed to the outer surface.

### Claim 21

A drug eluting implantable device comprising:
a framework comprising at least one stent wire, the stent wire including a first axial chamber and a second axial chamber, the first axial chamber separated from the second axial chamber by a wall;
a first drug disposed in the first axial chamber;
a second drug disposed in the second axial chamber; and
at least a first aperture between the first chamber and an outer surface of the framework, and a second aperture between the second chamber and the outer surface.

### Claim 22 (depends on 21)

The device of claim 21 wherein the first drug is an anti-restenotic agent.

### Claim 23 (depends on 22)

The device of claim 22 wherein the first drug is ABT-578.

### Claim 24 (depends on 21)

The device of claim 21 wherein the second drug is an anti-thrombotic agent.

### Claim 25 (depends on 24)

The device of claim 24 wherein the second drug is plavix.

### Claim 26 (depends on 21)

The device of claim 21 further comprising a third chamber within the stent wire, the third chamber separated from the first chamber and second chamber by at least one wall.

### Claim 27 (depends on 26)

The device of claim 26 further comprising a fourth chamber separated from the first chamber, second chamber, and third chamber by at least one wall.

### Claim 28

A method of administering a therapeutic agent at a target site, the method comprising:
receiving a medical device for implantation within a body lumen;
forming at least a first pocket including an opening on an exterior surface of the medical device;
disposing at least one therapeutic agent within the first pocket,
crimping the device with the therapeutic agent disposed within the first pocket;
forming a container from the pocket based on the crimping, at least a portion of the therapeutic agent disposed within the container;
expanding the device at a target site;
opening the container based on the expansion; and
administering the therapeutic agent at the target site responsive to the opened container.
